Research indicates that individuals taking **Ozempic** and similar **GLP-1 drugs** are saving an average of **5.5% on groceries**, amounting to approximately **$416 annually**.
The drugs, initially intended for diabetes management, are now widely used for **weight loss**, influencing spending habits and leading to a **decrease in purchases of snacks and sweets**.
Those with incomes over **$125,000** reported larger savings on groceries compared to lower-income individuals, particularly in categories like **chips and baked goods**.
Experts suggest this trend could prompt food manufacturers to adjust their products and pricing strategies in response to changing consumer preferences.
The study indicates that while grocery savings may decrease over time, the initial significant impact on spending patterns suggests a broader influence on the food industry.
For more details, visit the original article here.